Introduction
Anorexia nervosa (AN) is a serious mental health disorder with devastating consequences for sufferers and their families [1] . AN has a peak of onset in early adolescence [2] , an age of many developmental changes. AN with prepubertal onset (EO-AN) is relatively rare; however, the evidence is mixed on whether outcomes are worse or better compared to AN with onset after puberty. For many individuals, AN becomes a chronic disorder, with impact on the individual's social, physical and psychological functioning. The last 10 years have seen many novel investigations focusing on the neurobiology of AN. Cognitive characteristics of patients with AN have received much attention, parallel to a surge of interest in psychiatry for measurable biological processes or phenotypes that might be more biologically informed than current diagnostic categories.
In this issue, Van Noort and colleagues [3] aimed to investigate cognitive functioning in children with prepubertal onset AN, adolescents with AN, and two groups of age-matched controls. This design, i.e., including an age, gender and IQ-matched control sample for each index 1 3
State dependence: age, weight and state of illness matter
If cognitive weaknesses found to be associated with AN cross-sectionally are, in fact, state independent, one would expect rigidity and inefficiencies in global information processing to be present before disease onset, across ages and in addition, to be unrelated to weight changes. Existing evidence points to the opposite. Firstly, several studies suggest that children and adolescents with AN do not exhibit the same weak cognitive profile as that of adults. Findings from van Noort et al. in this issue provide similar evidence [3] . In this study, neither children with EO-AN nor adolescents with AN show central coherence, cognitive flexibility, planning, visuospatial skills, or cognitive inhibition inefficiencies compared to age, gender and IQ-matched controls. Secondly, when it comes to changes associated with weight gain, studies have shown improvements in cognitive domains, such as attention, executive function and central coherence following weight gain [9, 10] . Thirdly, mixed findings are present in relation to the presence of cognitive weaknesses in central coherence and cognitive flexibility in subjects recovered from AN [11] . Given this evidence, state independence of cognitive rigidity and global processing difficulties in subjects with AN remains to be confirmed, challenging the hypothesis that these are AN endophenotypes.
Alternative hypotheses and future steps
Studying cognitive characteristics in individuals at risk for or prior to AN onset is difficult. There is a paucity of large enough longitudinal studies following individuals from before onset of disorder into the period of risk in the field of eating disorders. A study of children at risk for AN (familial) is currently under way and might shed some light onto cognitive and brain characteristics in the absence of active disorder. More research is needed on disentangling the effect of physical consequences of active AN, such as starvation, specific nutrient depletion, and hypoestrogenism, on brain structure and function from pre-morbid cognitive and brain dys-function. Similarly, understanding possible long-term effects of the illness (scarring effects) on the brain and cognition might prove fruitful. AN is a heterogeneous disorder and the possibility that specific cognitive inefficiencies are present in a subgroup of individuals should not be ruled out. Although published genome-wide association studies (GWAS) of AN have not yielded positive findings, large genetic studies of AN are underway and these will provide robust markers of biological risk against which hypothesised endophenotypes can be tested.
Conclusions
Given the well-known limitations of diagnostic categories in psychiatry, the quest for endophenotypes, especially across disorders, is in full swing. The NIMH Research Domain Criteria (RDoC) initiative has stimulated a focus on measurable processes that link biological and genetic liability to clinical disorders. Progress from GWAS in identifying genetic markers of disease will undoubtedly allow a better understanding of whether endophenotypes will stand the test of time in psychiatric research. We still know little about the neurobiology of AN; longitudinal, clinical and at-risk studies will likely inform our conceptualisation of this devastating disorder in the next ten years. This evidence will in the long term allow refining existing treatment options and the potential development of new prevention and treatment strategies.
